Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | MIF | P14174 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.38 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.38 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.38 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.38 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11982130 | 1.00 | TDP1 (0.46) | TDP1MIFALDH1A1MEN1MAPT | |
| SCHEMBL9613490 | 1.00 | TDP1 (0.46) | TDP1MIFALDH1A1MEN1MAPT | |
| Cyclohexene SCHEMBL704338 | 0.94 | TDP1 (0.43) | TDP1MIFALDH1A1MEN1MAPT | |
| SCHEMBL5046323 | 0.89 | TP53 (0.47) | ALDH1A1MAPTTP53SMN1; SMN2CHRNB2 | |
| SCHEMBL4015650 | 0.86 | SMN1; SMN2 (0.45) | TDP1MIFALDH1A1MEN1MAPT | |
| SCHEMBL4015654 | 0.86 | SMN1; SMN2 (0.45) | TDP1MIFALDH1A1MEN1MAPT | |
| SCHEMBL637275 | 0.84 | — | — | |
| SCHEMBL17889899 | 0.83 | — | — | |
| SCHEMBL11536892 | 0.83 | MIF (0.47) | TDP1MIFALDH1A1MEN1MAPT | |
| SCHEMBL385399 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 324 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119978031-A | Preparation and application of molecular probe based on platinum chemotherapeutic drugs | 厦门大学 | 2025-05-13 | — | — | CN | claimed |
| CN-119899823-A | Lipase mutant, coding gene and application | 浙江工业大学 | 2025-04-29 | — | — | CN | claimed |
| CN-119899822-A | Lipase mutant, coding gene, vector and application | 浙江工业大学 | 2025-04-29 | — | — | CN | claimed |
| CN-119876088-A | Lipase mutant and application thereof in preparation of (S) -3-cyclohexene-1-carboxylic acid | 浙江工业大学 | 2025-04-25 | — | — | CN | claimed |
| CN-119876087-A | Lipase mutant and application thereof in preparation of (S) -3-cyclohexene-1-carboxylic acid | 浙江工业大学 | 2025-04-25 | — | — | CN | claimed |
| CN-119876086-A | Lipase mutant and application thereof | 浙江工业大学 | 2025-04-25 | — | — | CN | claimed |
| CN-119432809-A | Lipase mutant and application thereof | 浙江工业大学 | 2025-02-14 | — | — | CN | claimed |
| US-12188066-B2 | Method for resolving optical isomer by using supercritical fluid extraction technology | GUANG AN MOJIA BIOTECHNOLOGY CO., LTD. (CN) | 2025-01-07 | — | — | US | claimed |
| CN-119144580-A | Carboxylesterase mutant and application thereof in preparation of (S) -3-cyclohexene-1-carboxylic acid | 浙江大学 | 2024-12-17 | — | — | CN | claimed |
| CN-119019157-A | Large-size photo-curing 3D printing ceramic and preparation method thereof | 哈尔滨工业大学重庆研究院 | 2024-11-26 | — | — | CN | claimed |
| CN-114230976-A | Thermosetting resin composition and preparation method thereof | 上海中化科技有限公司 | 2022-03-25 | — | — | CN | claimed |
| EP-3960871-A1 | METHOD FOR RESOLVING OPTICAL ISOMER BY USING SUPERCRITICAL FLUID EXTRACTION TECHNOLOGY | Guang an Mojia Biotechnology Co., Ltd. (CN) | 2022-03-02 | — | — | EP | claimed |
| EP-3933043-A1 | METHOD FOR RESOLVING OPTICAL ISOMER BY MEANS OF ELECTRODIALYSIS TECHNIQUE | Guang an Mojia Biotechnology Co., Ltd. (CN) | 2022-01-05 | — | — | EP | claimed |
| CN-111850081-A | Method for resolving optical isomers using supercritical fluid extraction techniques | 广安摩珈生物科技有限公司 | 2020-10-30 | — | — | CN | claimed |
| WO-2020216295-A1 | METHOD FOR RESOLVING OPTICAL ISOMER BY USING SUPERCRITICAL FLUID EXTRACTION TECHNOLOGY | 广安摩珈生物科技有限公司 | 2020-10-29 | — | — | WO | claimed |
| CN-111621541-A | Method for resolving optical isomers using electrodialysis techniques | 上海艾美晶生物科技有限公司 | 2020-09-04 | — | — | CN | claimed |
| CN-103159245-A | A method for removing iron ions in drinking water-level polyaluminium chloride | CHANGZHOU YOUBANG WATER PURGING MATERIAL CO LTD | 2013-06-19 | — | — | CN | claimed |
| CN-103011223-A | Method for removing drinking water-level iron ions | UNIV CHANGZHOU | 2013-04-03 | — | — | CN | claimed |
| WO-2008106334-A2 | FLAME RETARDED STYRENIC POLYMER FOAMS AND FOAM PRECURSORS | ALBEMARLE CORPORATION (US) | 2008-09-04 | — | — | WO | claimed |
| US-5194669-A | Preparation of alkyl (alkoxycarbonylcyclohexyl) cyclohexenecarboxylates and dialkyl biphenyldicarboxylates | EASTMAN KODAK COMPANY (US) | 1993-03-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12188066-B2 | Method for resolving optical isomer by using supercritical fluid extraction technology | VKORC1L1, VKORC1, ADH7 | TDP1 3138/4885MIF 4839/4885ALDH1A1 726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.